Abstract

Introduction: Radon is the second most important cause of lung cancer after smoking. Thus, the determination of indoor radon concentrations in dwellings and workplaces is an important public health concern. The purpose of this research was to measure the concentration of radon gas in residential homes and public places in the city of Shiraz and its relationship with the type and age of the buildings as well as the type of materials used to construct the building (brick, block). We also determined the radon dosages that occupants of the building would receive. 

Methods: The present study is a descriptive-analytical and cross-sectional research that was conducted on the building’s indoor air in the city of Shiraz in 2015. Using geographic information system (GIS) software and a spatial sampling cell with an area of 25 square kilometers, 200 points were selected. In this study, we used passive diffusive samplers as Solid State Nuclear Track Detector (SSNTD) CR-39 polycarbonate films for three months in the winter. Sampling was conducted in accordance with the U.S. Environmental Protection Agency’s protocol. We determined the concentrations of radon gas at the time of sampling, and calibration factors were determined. The data were analyzed by IBM-SPSS, version 20, descriptive statistics, Kruskal-Wallis, and Mann–Whitney tests.

Results: This study showed that the average radon concentration was 57.6 ± 33.06 Bq/m3 in residential dwellings. The average effective dose was 1.45 mSv/y. The concentration of radon in 5.4% of the houses was found to be greater than 100 Bq/m3, which is above the level allowed by the World Health Organization (WHO). 

Conclusion: Since radon is the second leading cause of lung cancer, it seems necessary to increase the public’s awareness of this issue and to take action to reduce radon in homes when the concentrations are above the WHO’s guideline.

 

Keywords: Indoor radon, CR-39, Lung cancer, Shiraz, ICRP
 
» HTML Fulltext    » PDF Fulltext    » doi: 10.19082/2497
Off White X Max 180-90

Current Issue

Volume 12, issue 2, April-June 2020

 


 

The worldwide spread of COVID-19 as an emerging, rapidly evolving situation, and the dramatic need of urgent medicine or vaccine, has rapidly brought new hypotheses for pathophysiology and potential medicinal agents to the fore. It is crucial that the research community provide a way to publish this research in a timely manner.

To contribute to this important public health discussion, the Electronic Physician Journal is excited to announce a fast-track procedure to help researchers publish their articles on COVID-19 related subjects that fall under the broad definition of public health, internal medicine, and pharmacology. We are especially welcome to all hypotheses about the pathological basis of the COVID-19 infection and the possible characteristics of potential medicine and vaccine. Submit your manuscript here


 

The 6th World Conference on Research Integrity (WCRI) is to be held on June 2-5, 2019 in Hong Kong.

The WCRI is the largest and most significant international conference on research integrity. Since the first conference in Lisbon in 2007, it has given researchers, teachers, funding agencies, government officials, journal editors, senior administrators, and research students opportunities to share experiences and to discuss and promote integrity in research. Read more:


 

TDR Clinical Research and Development Fellowships

Call for applications

Deadline for submission: 7 March 2019, 16:00 (GMT)

TDR provides fellowships for early- to mid-career researchers and clinical trial staff (e.g. clinicians, pharmacists, medical statisticians, data managers, other health researchers) in low- and middle-income countries (LMICs) to learn how to conduct clinical trials. Read more:


Meta-Analysis Workshops in New York, USA, and London, UK, in April and May 2019

Don't miss this exceptional opportunity to learn how to perform and report a Meta-analysis correctly. Two Meta-analysis workshops are organized in April and May 2019 by Dr. Michael Borenstein in New York, USA (April 08-10, 2019) and London, UK (May 27-29).

About the Instructor

Dr. Michael Borenstein, one of the authors of Introduction to Meta-Analysis, is widely recognized for his ability to make statistical concepts accessible to researchers as well as to statisticians. He has lectured widely on meta-analysis, including at the NIH, CDC, and FDA. Read more: